Mirae Asset Global ETFs Holdings
MIRA icon

Mirae Asset Global ETFs Holdings’s MIRA Pharmaceuticals MIRA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-312,777
Closed -$472K – 3160
2025
Q4 		$472K Buy
+312,777
New +$460K ﹤0.01% 1923

Other funds holding MIRA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's MIRA Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings sold out of MIRA Pharmaceuticals (MIRA) in Q1 2026, closing a stake of 312,777 shares — an estimated $472K sold.

Mirae Asset Global ETFs Holdings first reported a position in MIRA in Q4 2025 and held it in 1 quarter. The position peaked at $472K in Q4 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

  • Mirae Asset Global ETFs Holdings reported no remaining MIRA Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 312,777 MIRA Pharmaceuticals shares in Q1 2026, an estimated $472K.
  • Mirae Asset Global ETFs Holdings first reported a position in MIRA Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Mirae Asset Global ETFs Holdings's MIRA Pharmaceuticals position peaked at $472K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.